Afrocentric Investment (JSE:ACT) Growth Rank: 1 (As of Jul. 25, 2026) — 89% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

JSE:ACT Afrocentric Investment Corp Ltd JSE:ACT
52 GF Score
Price R0.80
GF Value R2.06
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Afrocentric Investment Growth Rank?

Afrocentric Investment JSE:ACT 52 Growth Rank is 1 as of Jul. 25, 2026, which is 89% below its 10-year median of 9.00. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.06 (Possible Value Trap). The stock has 6 warning signs investors should review.

Afrocentric Investment has the Growth Rank of 1.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Afrocentric Investment Growth Rank Related Terms

JSE:ACT vs HCA, THC, DVA: Growth Rank Comparison

For the Medical Care Facilities subindustry, Afrocentric Investment's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Afrocentric Investment Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's Growth Rank distribution charts can be found below:

* The bar in red indicates where Afrocentric Investment's Growth Rank falls into.


JSE:ACT
52GF Score
Afrocentric Investment Corp Ltd JSE:ACT
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 1 mean?
Afrocentric Investment (JSE:ACT) has a Growth Rank of 1 as of Jul. 25, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Afrocentric Investment and its competitors. This is 89% below median its historical median of 9.00. Over the past decade, Afrocentric Investment's Growth Rank has ranged from 1.00 to 10.00.
Is Afrocentric Investment's Growth Rank too high?
Afrocentric Investment's current Growth Rank of 1 is 89% below median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's Growth Rank compare to HCA and THC?
Afrocentric Investment's Growth Rank of 1 can be compared against companies in the Healthcare Providers & Services industry. Historically, Afrocentric Investment's own Growth Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Afrocentric Investment and its competitors. Afrocentric Investment's current Growth Rank is 1, which is 89% below median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.06, compared to a current price of R0.80 — trading 61.2% below its estimated fair value. The current Growth Rank is 1, which is 89% below median its 10-year median of 9.00. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current Growth Rank is 1 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?

Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued. The current stock price of R0.80 is trading 61.2% below its estimated GF Value™ of R2.06. GuruFocus considers Afrocentric Investment to be Possible Value Trap.

Key valuation signals for JSE:ACT:

  • Growth Rank: 1 (89% below median its 10-year median of 9.00)
  • GF Value™: R2.06 vs. price of R0.80 (61.2% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Afrocentric Investment Business Description

Address 37 Conrad Road, Florida North, Roodepoort, ZAF, 1709
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score

Get the complete analysis for JSE:ACT

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R0.80
Price
R2.06
GF Value